Biomerica, Inc. BMRA shares are trading higher on Thursday due to strong momentum.
Biomerica is engaged in the development, manufacturing, and marketing medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. Majority of the company's revenue is earned from the Europe market.
Biomerica shares were trading up 18.41% at $11.32 on Thursday. The stock has a 52-week high of $23.39 and a 52-week low of $2.05.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
